Username Password
S&P 500: 1,351.60 Change: +0.14%

MIDAS GROUP INC (MDS)

Overview
Price 9.45
Price Change Today -$0.02 (-0.21%)
P&P rating Rating: 0
Zacks Rank 3 - HOLD
Open Price $9.36
Previous Close $9.47
Daily Range $9.36 - $9.45
52-Week Range $5.08 - $10.07
Volume 7,096
chart
Midas, Inc. provides services in the U.S., Canada, France and other locations in Europe, Australia, the Middle East, Latin America and the Caribbean. Midas shops offer exhaust, brake, suspension, air conditioning and maintenance services. Midas brand products are sold at wholesale to franchised Midas shops and at retail by company-operated shops. IPC brand exhaust products are sold to distributors. Midas also manufactures and sells shop equipment under the Huth trademark. Midas Realty Corp., a Midas subsidiary, selects, leases, acquires and constructs sites for Midas shops.
Other Resources for MDS
zacks.com
Commentary
No Commentary Found for This Ticker.
Midas, Inc. provides services in the U.S., Canada, France and other locations in Europe, Australia, the Middle East, Latin America and the Caribbean. Midas shops offer exhaust, brake, suspension, air conditioning and maintenance services. Midas brand products are sold at wholesale to franchised Midas shops and at retail by company-operated shops. IPC brand exhaust products are sold to distributors. Midas also manufactures and sells shop equipment under the Huth trademark. Midas Realty Corp., a Midas subsidiary, selects, leases, acquires and constructs sites for Midas shops.
 
Brokerage Analyst Recommendations
2 Brokerage Firms Covering MDS
 
 
Strong Buy
0
Buy
0
Hold
2
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 3
 
MDS Ratings:BUY  SELL  HOLD
MDS Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

0 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 01/10/12 Celgene's Preliminary Earnings Impress - Analyst Blog 0
Zacks_Analysts
0.00 12/12/11 Celgene Presents Positive Data - Analyst Blog 0
Zacks_Analysts
0.00 11/23/11 Celgene's Revlimid Cleared in Sweden - Analyst Blog 0
Zacks_Analysts
0.00 09/27/11 Good News for Celgene - Analyst Blog 0
Zacks_Analysts
0.00 08/23/11 Evenly Poised Cell Therapeutics - Analyst Blog 0
Zacks_Analysts
0.00 07/15/11 BioMarin Starts Study on BMN673 - Analyst Blog 0
Zacks_Analysts
0.00 05/06/11 Mixed Results for CELG's Revlimid - Analyst Blog 0
Zacks_Analysts
0.00 05/02/11 Loss Widens at Cell Therapeutics - Analyst Blog 0
Zacks_Analysts
0.00 03/15/11 CTIC Strikes Cancer Deal with Chroma - Analyst Blog 0
Zacks_Analysts
0.00 01/05/11 CELG seeks Label Expansion - Analyst Blog 0
Pages: [ 1 ]  2   3   4  >>
Commentary
There are no open picks with this stock at the moment.
Picks
There are no open picks with this stock at the moment.
Sponsored Links